Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase igf1r'

Search results for: 'research area tyrosine kinase igf1r'

Items 1-10 of 211

Page
per page
  1. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: Selective IGF-1R/IR inhibitor
      ≥42.6 mg/mL
  2. NVP-AEW541
    A2278 NVP-AEW541
    Target: Insulin Receptor
    Summary: IGF-IR inhibitor, novel, potent and selective
      ≥22 mg/mL
  3. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  4. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  5. [Ser25] Protein Kinase C (19-31)
    A1033 [Ser25] Protein Kinase C (19-31)
    Summary: PKC substrate
      insoluble in EtOH; ≥155.9 mg/mL
  6. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  7. Compound 56
    A8197 Compound 56
     1 Citation
    Target: EGFR
    Summary: REGFR inhibitor
      insoluble in H2O; ≥16.95 mg/mL
  8. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  9. Nilotinib(AMN-107)
    A8232 Nilotinib(AMN-107)
     1 Citation
    Target: Bcr-Abl
    Summary: Bcr-Abl kinase inhibitor,selective
      ≥26.5 mg/mL
  10. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL

Items 1-10 of 211

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 206item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 1 item
Specificity
  1. Selective 129item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 10item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 17item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 3item
  4. PI3K 9item
  5. Raf 8item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 6item
  9. FLT3 11item
  10. GSK-3 5item
  11. PLK 5item
  12. Chk 3item
  13. Eph Receptors 2item
  14. VEGFR 22item
  15. PDGFR 16item
  16. c-Kit 9item
  17. RET 2item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 4item
  21. PKB 1 item
  22. Bcr-Abl 8item
  23. MEK 2item
  24. FGFR 8item
  25. Pim 3item
  26. Voltage-gated Sodium (NaV) Channels 1 item
  27. MET 3item
  28. Src 13item
  29. Trk Receptors 1 item
  30. STAT 3item
  31. EGFR 15item
  32. ROCK 3item
  33. FAK 2item
  34. JAK 13item
  35. Syk 3item
  36. DNA-PK 3item
  37. AMPK 1 item
  38. Cytochrome P450 (CYP450) 1 item
  39. ErbB 3item
  40. ERK 3item
  41. c-MET 4item
  42. PKC 9item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  44. Lyn 1 item
  45. Pyk2 2item
  46. LRRK2 5item
  47. Insulin and Insulin-like Receptors 3item
  48. ALK 4item
  49. Sphingosine kinases (SphKs) 2item
  50. PKG 1 item
  51. PKA 3item
  52. Myosin light chain kinases (MLCKs) 1 item
  53. MK2 1 item
  54. Angiotensin-Converting Enzymes (ACEs) 1 item
  55. Tie-2 1 item
  56. RSK 2item
  57. phosphatases 1 item
  58. ATM/ATR 3item
  59. Farnesyl Diphosphate Synthases 1 item
  60. CK2 3item
  61. HIPK2 1 item
  62. HIPK3 1 item
  63. P2X Receptors 1 item
  64. Histamine H1 Receptors 1 item
  65. P110 1 item
  66. Hck 2item
  67. MNK 1 item
  68. 5-Lipoxygenases 1 item
  69. Insulin Receptors 1 item
  70. IRG-1R 1 item
  71. Cdc2-like kinase (Clk) 1 item
  72. eEF-2 1 item
  73. Cdc7 1 item
  74. ZAP-70 1 item
  75. c-RET 3item
  76. p70 rsk 2item
  77. VEGFR3/FLT4 1 item
  78. NTRK1/TRKA 1 item
  79. CSF-1R/c-Fms 1 item
  80. TAM kinase 1 item
  81. KDR 1 item
  82. Fyn kinase 1 item
  83. Abl kinases 1 item
  84. AXL 1 item
  85. c-Fms tyrosine kinase 1 item
  86. insulin 1 item
  87. STK 1 item
  88. MSK 1 item
  89. Lyn kinase 1 item
  90. Mer tyrosine kinase 1 item
  91. ErbB-2 1 item
  92. PDK-1 1 item
  93. Histone Acetyltransferases (HATs) 1 item
  94. Prk 1 item
  95. ITK 1 item
  96. NUAK 1 item
  97. DCLK2 1 item
  98. PTK 1 item
  99. phosphatidylinositol kinase 1 item
  100. Lck 1 item
  101. Flk1 2item
  102. Protein Tyrosine Phosphatases 1 item
  103. alkaline phosphatases 1 item
  104. ATPases 1 item
  105. glutamate release 1 item
  106. FGR 1 item
  107. YES 2item
  108. Fyn 2item
  109. ARG 1 item
  110. TRPC channel 1 item
  111. PKD 1 item
  112. Pyruvate kinases 1 item
  113. enoyl-acyl-carrier protein reductase 1 item
  114. Rho-kinase 1 item
  115. tropomyosin receptor kinase 1 item
  116. SK 1 item
  117. PPK 1 item
  118. c-Syk 1 item
  119. CDK1/CyclinB 1 item
  120. PIM1 kinase 1 item
  121. phospholipase A2 1 item
  122. PIKfyve 1 item
  123. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 10item
  2. Adrenocortical Carcinoma 2item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. B-lymphoid Malignancies 1 item
  6. Breast Cancer 22item
  7. Cancer 122item
  8. Cervical Cancer 3item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 10item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 13item
  15. Glioblastoma 10item
  16. Glioma 4item
  17. Hepatocellular Carcinoma 3item
  18. HIV Infections 1 item
  19. Leukemia 6item
  20. Liver Cancer 2item
  21. Lung Cancer 5item
  22. Lung Carcinoma 1 item
  23. Lymphoma 7item
  24. Mantle Cell Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 3item
  27. Myelofibrosis 1 item
  28. Non-small Cell Lung Cancer 4item
  29. Ovarian Cancer 9item
  30. Pancreatic Cancer 13item
  31. Prostate Cancer 7item
  32. Psoriasis 1 item
  33. Renal Cancer 2item
  34. Renal Cell Carcinoma 2item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 3item
  37. Type 2 Diabetes 1 item